The DOI matches its Crossref record; 434 of the 434 references it cites were found in a registry or an index.
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Open accessAbstract
The chemokine receptors CXCR1/2 and their ligand CXCL8 are essential for the activation and trafficking of inflammatory mediators as well as tumor progression and metastasis. The CXCL8-CXCR1/2 signaling axis is involved in the pathogenesis of several diseases including chronic obstructive pulmonary diseases (COPD), asthma, cystic fibrosis and cancer. Interaction between CXCL8 secreted by select cancer cells and CXCR1/2 in the tumor microenvironment is critical for cancer progression and metastasis. The CXCL8-CXCR1/2 axis may play an important role in tumor progression and metastasis by regulating cancer stem cell (CSC) proliferation and self-renewal. During the past two decades, several small-molecule CXCR1/2 inhibitors, CXCL8 releasing inhibitors, and neutralizing antibodies against CXCL8 and CXCR1/2 have been reported. As single agents, such inhibitors are expected to be efficacious in various inflammatory diseases. Several preclinical studies suggest that combination of CXCR1/2 inhibitors along with other targeted therapies, chemotherapies, and immunotherapy may be effective in treating select cancers. Currently, several of these inhibitors are in advanced clinical trials for COPD, asthma, and metastatic breast cancer. In this review, we provide a comprehensive analysis of the role of the CXCL8-CXCR1/2 axis and select genes co-expressed in this pathway in disease progression. We also discuss the latest progress in developing small-molecule drugs targeting this pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
The NF- B Family of Transcription Factors and Its Regulation
Oeckinghaus, A., & Ghosh, S. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000034 · Cited by 2,842
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3369 · Cited by 1,332
The Molecular Biology of Leukocyte Chemoattractant Receptors
Murphy, P. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003113 · Cited by 1,195
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,122
Structure and Functional Expression of a Human Interleukin-8 Receptor
Holmes, W. E., Lee, J., Kuang, W.-J., Rice, G. C., & Wood, W. I. (1991) · Science · doi:10.1126/science.1840701 · Cited by 1,090
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085 · cited 2×
“Chemokines for CXCR1/2 including CXCL1, 5, 7, and 8 are secreted and expressed by various cancer cell types and stimulate cancer cell proliferation and migration in an autocrine fashion [229-236].”
Multiple control of interleukin-8 gene expression
Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., & Kracht, M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.847 · Cited by 1,058
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 982
Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor
Murphy, P. M., & Tiffany, H. L. (1991) · Science · doi:10.1126/science.1891716 · Cited by 871
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P., Upstill-Goddard, R., Rishi, L., Foth, M., Bryson, S., McDaid, K., Wilson, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.014 · Cited by 845
CLATHRIN-COATED VESICLE FORMATION AND PROTEIN SORTING: An Integrated Process
Schmid, S. L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.511 · Cited by 799
CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow
Eash, K. J., Greenbaum, A. M., Gopalan, P. K., & Link, D. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41649 · Cited by 791
Winzen, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.4969 · Cited by 777
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., & Mackall, C. L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007974 · Cited by 767 · cited 5×
“Inhibition of programmed death-1 (PD-1) by anti-PD-1 antibody prevented tumor growth during early phase tumor progression, but delayed treatment with anti-PD-1 therapy showed little benefits [346].”
InfluentialThe role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., Stolz, D. B., Land, S. R., Marconcini, L. A., Kliment, C. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2084 · Cited by 744
Mediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & McGarry Houghton, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 707
Chronic inflammation and cancer.
Shacter, E. B., & Weitzman, S. A. (2002) · PubMed · Cited by 694
Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement
Parsons, J. T., Martin, K. H., Slack, J. K., Taylor, J. M., & Weed, S. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203877 · Cited by 672
Neutrophil and B Cell Expansion in Mice That Lack the Murine IL-8 Receptor Homolog
Cacalano, G., Lee, J., Kikly, K., Ryan, A. M., Pitts-Meek, S., Hultgren, B., Wood, W. I., & Moore, M. W. (1994) · Science · doi:10.1126/science.8036519 · Cited by 664
The CXCL8-CXCR1/2 pathways in cancer
Liu, Q., Li, A., Tian, Y., Wu, J. D., Liu, Y., Li, T., Chen, Y., Han, X., & Wu, K. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.002 · Cited by 662
A novel neutrophil-activating factor produced by human mononuclear phagocytes.
Peveri, P., Walz, A., Dewald, B., & Baggiolini, M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1547 · Cited by 647
Identification and consequences of miRNA–target interactions — beyond repression of gene expression
Hausser, J., & Zavolan, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3765 · Cited by 628
Rollins, B. J. (1997) · PubMed · Cited by 603
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., & Strieter, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5269 · Cited by 575
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Schröder, J. M., Mrowietz, U., Morita, E., & Christophers, E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.10.3474 · Cited by 531
Walz, A., Peveri, P., Aschauer, H., & Baggiolini, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90432-3 · Cited by 505
NF-κB Subunit-Specific Regulation of the Interleukin-8 Promoter
Kunsch, C., & Rosen, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6137-6146.1993 · Cited by 493
Airways Obstruction and the Risk for Lung Cancer
TOCKMAN, M. S., ANTHONISEN, N. R., WRIGHT, E. C., & DONITHAN, M. G. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-512 · Cited by 472
AARON, S. D., ANGEL, J. B., LUNAU, M., WRIGHT, K., FEX, C., LE SAUX, N., & DALES, R. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2003122 · Cited by 466
Structure of the chemokine receptor CXCR1 in phospholipid bilayers
Park, S. H., Das, B. B., Casagrande, F., Tian, Y., Nothnagel, H. J., Chu, M., Kiefer, H., Maier, K., De Angelis, A. A., Marassi, F. M., et al. (2012) · Nature · doi:10.1038/nature11580 · Cited by 457
SKILLRUD, D. M., OFFORD, K. P., & MILLER, R. D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-4-503 · Cited by 442
White, J. R., Lee, J. M., Young, P. R., Hertzberg, R. P., Jurewicz, A. J., Chaikin, M. A., Widdowson, K., Foley, J. J., Martin, L. D., Griswold, D. E., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10095 · Cited by 432
Delayed Wound Healing in CXCR2 Knockout Mice
Devalaraja, R. M., Nanney, L. B., Qian, Q., Du, J., Yu, Y., Devalaraja, M. N., & Richmond, A. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00034.x · Cited by 429
Clark-Lewis, I., Schumacher, C., Baggiolini, M., & Moser, B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54472-0 · Cited by 425
Ahuja, S. K., & Murphy, P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20545 · Cited by 418
Signals and Receptors Involved in Recruitment of Inflammatory Cells
Ben-Baruch, A., Michiel, D. F., & Oppenheim, J. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.11703 · Cited by 411
Ning, Y., Manegold, P. C., Hong, Y. K., Zhang, W., Pohl, A., Lurje, G., Winder, T., Yang, D., LaBonte, M. J., Wilson, P. M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25562 · Cited by 406
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury
Belperio, J. A., Keane, M. P., Burdick, M. D., Londhe, V. A., Xue, Y., Li, K., Phillips, R. J., & Strieter, R. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15849 · Cited by 402
Fernando, R. I., Castillo, M. D., Litzinger, M., Hamilton, D. H., & Palena, C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0156 · Cited by 400
Linking cargo to vesicle formation: receptor tail interactions with coat proteins
Kirchhausen, T., Bonifacino, J. S., & Riezman, H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80024-5 · Cited by 399
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
David, J., Dominguez, C., Hamilton, D., & Palena, C. (2016) · Vaccines · doi:10.3390/vaccines4030022 · Cited by 395
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J. B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61067 · Cited by 391
Martin, D., Galisteo, R., & Gutkind, J. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c800207200 · Cited by 388
Cowley, G. S., Weir, B. A., Vazquez, F., Tamayo, P., Scott, J. A., Rusin, S., East-Seletsky, A., Ali, L. D., Gerath, W. F., Pantel, S. E., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.35 · Cited by 387
Expression of chemokine receptors by subsets of neurons in the central nervous system
Horuk, R., Martin, A. W., Wang, Z., Schweitzer, L., Gerassimides, A., Guo, H., Lu, Z., Hesselgesser, J., Perez, H. D., Kim, J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2882 · Cited by 385
G protein-coupled signal transduction pathways for interleukin-8
Wu, D., LaRosa, G., & Simon, M. (1993) · Science · doi:10.1126/science.8316840 · Cited by 382
Hébert, C. A., Vitangcol, R. V., & Baker, J. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55160-7 · Cited by 369
Inoue, K., Slaton, J. W., Eve, B. Y., Kim, S. J., Perrotte, P., Balbay, M. D., Yano, S., Bar‐Eli, M., Radinsky, R., Pettaway, C. A., et al. (2000) · PubMed · Cited by 361
Huang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X.-D., Gudas, J. M., & Bar-Eli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64164-8 · Cited by 361
Neutrophil Activation by Monomeric Interleukin-8
Rajarathnam, K., Sykes, B. D., Kay, C. M., Dewald, B., Geiser, T., Baggiolini, M., & Clark-Lewis, I. (1994) · Science · doi:10.1126/science.8140420 · Cited by 356
Benoy, I. H., Salgado, R., Van Dam, P., Geboers, K., Van Marck, E., Scharpé, S., Vermeulen, P. B., & Dirix, L. Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0812 · Cited by 356
Crystal structure of interleukin 8: symbiosis of NMR and crystallography.
Baldwin, E. T., Weber, I. T., St Charles, R., Xuan, J. C., Appella, E., Yamada, M., Matsushima, K., Edwards, B. F., Clore, G. M., & Gronenborn, A. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.502 · Cited by 354
The role of clathrin, adaptors and dynamin in endocytosis
Robinson, M. S. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90074-4 · Cited by 349
Neutrophil Recruitment to the Lungs during Bacterial Pneumonia
Craig, A., Mai, J., Cai, S., & Jeyaseelan, S. (2009) · Infection and Immunity · doi:10.1128/iai.00832-08 · Cited by 349
Banks, C., Bateman, A., Payne, R., Johnson, P., & Sheron, N. (2003) · The Journal of Pathology · doi:10.1002/path.1245 · Cited by 344
A clinically relevant gene signature in triple negative and basal-like breast cancer
Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr3035 · Cited by 338
Nair, P., Gaga, M., Zervas, E., Alagha, K., Hargreave, F. E., O'Byrne, P. M., Stryszak, P., Gann, L., Sadeh, J., Chanez, P., et al. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04014.x · Cited by 333
Bertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M. N., Di Cioccio, V., Cesta, M. C., Galliera, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402090101 · Cited by 333
Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung
Reutershan, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27009 · Cited by 322
Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease
Hartl, D., Latzin, P., Hordijk, P., Marcos, V., Rudolph, C., Woischnik, M., Krauss-Etschmann, S., Koller, B., Reinhardt, D., Roscher, A. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1690 · Cited by 322
Knall, C., Worthen, G. S., & Johnson, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3052 · Cited by 321
Neutrophils: key mediators of tumour angiogenesis
Tazzyman, S., Lewis, C. E., & Murdoch, C. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00641.x · Cited by 318
The GPCR Network: a large-scale collaboration to determine human GPCR structure and function
Stevens, R. C., Cherezov, V., Katritch, V., Abagyan, R., Kuhn, P., Rosen, H., & Wüthrich, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3859 · Cited by 316
Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004) · PubMed · Cited by 312
Richman-Eisenstat, J. B., Jorens, P. G., Hebert, C. A., Ueki, I., & Nadel, J. A. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.264.4.l413 · Cited by 307
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Airway Inflammation in COPD Assessed by Sputum Levels of lnterleukin-8*
Yamamoto, C., Yoneda, T., Yoshikawa, M., Fu, A., Tokayama, T., Tsukaguchi, K., & Narita, N. (1997) · Chest · doi:10.1378/chest.112.2.505 · Cited by 301
Bronchial Neutrophilia in Patients with Noninfectious Status Asthmaticus
LAMBLIN, C., GOSSET, P., TILLIE-LEBLOND, I., SAULNIER, F., MARQUETTE, C.-H., WALLAERT, B., & TONNEL, A. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.97-02099 · Cited by 296
Lee, Y. S., Choi, I., Ning, Y., Kim, N. Y., Khatchadourian, V, Yang, D., Chung, H. K., Choi, D., LaBonte, M. J., Ladner, R. D., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.177 · Cited by 292
Ridley, S. H., Sarsfield, S. J., Lee, J. C., Bigg, H. F., Cawston, T. E., Taylor, D. J., DeWitt, D. L., & Saklatvala, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3165 · Cited by 286
IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways
Schraufstatter, I. U., Chung, J., & Burger, M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1094 · Cited by 278
Zhang, H., Ye, Y.-L., Li, M.-X., Ye, S.-B., Huang, W.-R., Cai, T.-T., He, J., Peng, J.-Y., Duan, T.-H., Cui, J., et al. (2017) · Oncogene · doi:10.1038/onc.2016.367 · Cited by 278
Hepatic platelet and leukocyte adherence during endotoxemia
Croner, R. S., Hoerer, E., Kulu, Y., Hackert, T., Gebhard, M.-M., Herfarth, C., & Klar, E. (2006) · Critical Care · doi:10.1186/cc3968 · Cited by 275
Small Molecule Inhibitors of CXCR4
Debnath, B., Xu, S., Grande, F., Garofalo, A., & Neamati, N. (2013) · Theranostics · doi:10.7150/thno.5376 · Cited by 273
Self-citationNORZILA, M. Z., FAKES, K., HENRY, R. L., SIMPSON, J., & GIBSON, P. G. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9809071 · Cited by 269
Jones, S. A., Wolf, M., Qin, S., Mackay, C. R., & Baggiolini, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6682 · Cited by 265
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Rennard, S. I., Dale, D. C., Donohue, J. F., Kanniess, F., Magnussen, H., Sutherland, E. R., Watz, H., Lu, S., Stryszak, P., Rosenberg, E., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0992oc · Cited by 261
Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD
Mahler, D. A., Huang, S., Tabrizi, M., & Bell, G. M. (2004) · Chest · doi:10.1378/chest.126.3.926 · Cited by 261
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42754 · Cited by 256 · cited 2×
“Treatment with a CXCR2 inhibitor or knock down of CXCR2 in the stromal cells delayed tumor growth in a mixed cell xenograft model [372, 373].”
Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells
Singh, J. K., Simões, B. M., Howell, S. J., Farnie, G., & Clarke, R. B. (2013) · Breast Cancer Research · doi:10.1186/bcr3436 · Cited by 249
Otvos, B., Silver, D. J., Mulkearns-Hubert, E. E., Alvarado, A. G., Turaga, S. M., Sorensen, M. D., Rayman, P., Flavahan, W. A., Hale, J. S., Stoltz, K., et al. (2016) · Stem Cells · doi:10.1002/stem.2393 · Cited by 245
Knall, C., Young, S., Nick, J. A., Buhl, A. M., Worthen, G. S., & Johnson, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2832 · Cited by 242
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
Zhu, Y. M., Webster, S. J., Flower, D., & Woll, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602227 · Cited by 241
Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor
Chuntharapai, A., & Kim, K. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2587 · Cited by 240
Neutrophil Chemotactic Activity of Sputum From Patients With COPD
Beeh, K. M., Kornmann, O., Buhl, R., Culpitt, S. V., Giembycz, M. A., & Barnes, P. J. (2003) · Chest · doi:10.1378/chest.123.4.1240 · Cited by 233
Luppi, F., Longo, A. M., de Boer, W. I., Rabe, K. F., & Hiemstra, P. S. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.11.014 · Cited by 228
Wu, G. D., Lai, E. J., Huang, N., & Wen, X. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2396 · Cited by 224
Dean, T. P., Dai, Y., Shute, J. K., Church, M. K., & Warner, J. O. (1993) · Pediatric Research · doi:10.1203/00006450-199308000-00010 · Cited by 221
Petreaca, M. L., Yao, M., Liu, Y., DeFea, K., & Martins-Green, M. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0004 · Cited by 219
Singh, J. K., Farnie, G., Bundred, N. J., Simões, B. M., Shergill, A., Landberg, G., Howell, S. J., & Clarke, R. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1063 · Cited by 217
Wolf, J., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., Yeh, N. T., Mukaida, N., & Waes, C. V. (2001) · PubMed · Cited by 215
Brandenburg, S., Müller, A., Turkowski, K., Radev, Y. T., Rot, S., Schmidt, C., Bungert, A. D., Acker, G., Schorr, A., Hippe, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1529-6 · Cited by 215
Liu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., Padovani-Claudio, D., He, T., Choi, K., Lane, T. E., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2491 · Cited by 214
Li, A., Varney, M. L., & Singh, R. K. (2001) · PubMed · Cited by 214
Del Rio, L., Bennouna, S., Salinas, J., & Denkers, E. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6503 · Cited by 207
Kim, S. J., Uehara, H., Karashima, T., Mccarty, M., Shih, N., & Fidler, I. J. (2001) · Neoplasia · doi:10.1038/sj.neo.7900124 · Cited by 206
Reich, K., Papp, K. A., Matheson, R. T., Tu, J. H., Bissonnette, R., Bourcier, M., Gratton, D., Kunynetz, R. A., Poulin, Y., Rosoph, L. A., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12710 · Cited by 204
Switch to the angiogenic phenotype during tumorigenesis.
Folkman, J., & Hanahan, D. (1991) · PubMed · Cited by 200
Maxwell, P. J., Gallagher, R., Seaton, A., Wilson, C., Scullin, P., Pettigrew, J., Stratford, I. J., Williams, K. J., Johnston, P. G., & Waugh, D. J. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210536 · Cited by 199
Lee, L.-F., Li, G., Templeton, D. J., & Ting, J. P.-Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28253 · Cited by 197
Glioblastoma Stem Cells Are Regulated by Interleukin-8 Signaling in a Tumoral Perivascular Niche
Infanger, D. W., Cho, Y., Lopez, B. S., Mohanan, S., Liu, S. C., Gursel, D., Boockvar, J. A., & Fischbach, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1355 · Cited by 184
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
Holz, O., Khalilieh, S., Ludwig-Sengpiel, A., Watz, H., Stryszak, P., Soni, P., Tsai, M., Sadeh, J., & Magnussen, H. (2010) · European Respiratory Journal · doi:10.1183/09031936.00048509 · Cited by 183
Yang, G., Rosen, D. G., Liu, G., Yang, F., Guo, X., Xiao, X., Xue, F., Mercado-Uribe, I., Huang, J., Lin, S.-H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0483 · Cited by 183
Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
Nasser, M. W., Raghuwanshi, S. K., Grant, D. J., Jala, V. R., Rajarathnam, K., & Richardson, R. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900305 · Cited by 183
Stadtmann, A., & Zarbock, A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00263 · Cited by 182
SAGEL, S. D., KAPSNER, R., OSBERG, I., SONTAG, M. K., & ACCURSO, F. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2104075 · Cited by 182
Schultheis, A. M., Lurje, G., Rhodes, K. E., Zhang, W., Yang, D., Garcia, A. A., Morgan, R., Gandara, D., Scudder, S., Oza, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0351 · Cited by 182
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells
Schinke, C., Giricz, O., Li, W., Shastri, A., Gordon, S., Barreyro, L., Bhagat, T., Bhattacharyya, S., Ramachandra, N., Bartenstein, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621631 · Cited by 180
Why Integrin as a Primary Target for Imaging and Therapy
Niu, G., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0030 · Cited by 179
Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer
Li, A., King, J., Moro, A., Sugi, M. D., Dawson, D. W., Kaplan, J., Li, G., Lu, X., Strieter, R. M., Burdick, M., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.058 · Cited by 177
Skov, L., Beurskens, F. J., Zachariae, C. O. C., Reitamo, S., Teeling, J., Satijn, D., Knudsen, K. M., Boot, E. P. J., Hudson, D., Baadsgaard, O., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.669 · Cited by 177
Manthey, C. L., Wang, S.-W., Kinney, S. D., & Yao, Z. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.409 · Cited by 175
Bonnett, C. R., Cornish, E. J., Harmsen, A. G., & Burritt, J. B. (2006) · Infection and Immunity · doi:10.1128/iai.00909-06 · Cited by 174
Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity.
LaRosa, G. J., Thomas, K. M., Kaufmann, M. E., Mark, R., White, M., Taylor, L., Gray, G., Witt, D., & Navarro, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74055-1 · Cited by 174
Zhang, J., Yang, J., Jang, R., & Zhang, Y. (2015) · Structure · doi:10.1016/j.str.2015.06.007 · Cited by 172
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Bonavia, R., Inda, M. M., Vandenberg, S., Cheng, S.-Y., Nagane, M., Hadwiger, P., Tan, P., Sah, D. W. Y., Cavenee, W. K., & Furnari, F. B. (2012) · Oncogene · doi:10.1038/onc.2011.563 · Cited by 170
Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer
Veltri, R. W., Miller, M. C., Zhao, G., Ng, A., Marley, G. M., Wright, G. L., Vessella, R. L., & Ralph, D. (1999) · Urology · doi:10.1016/s0090-4295(98)00455-5 · Cited by 169
Chen, L., Fan, J., Chen, H., Meng, Z., Chen, Z., Wang, P., & Liu, L. (2014) · Scientific Reports · doi:10.1038/srep05911 · Cited by 169
Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2
Traves, S. L., Smith, S. J., Barnes, P. J., & Donnelly, L. E. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003495 · Cited by 169
Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease
Koelink, P. J., Overbeek, S. A., Braber, S., Morgan, M. E., Henricks, P. A. J., Roda, M. A., Verspaget, H. W., Wolfkamp, S. C., te Velde, A. A., Jones, C. W., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303252 · Cited by 168
Tabary, O., Zahm, J. M., Hinnrasky, J., Couetil, J. P., Cornillet, P., Guenounou, M., Gaillard, D., Puchelle, E., & Jacquot, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65633-7 · Cited by 166
Saintigny, P., Massarelli, E., Lin, S., Ahn, Y.-H., Chen, Y., Goswami, S., Erez, B., O'Reilly, M. S., Liu, D., Lee, J. J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0263 · Cited by 166
Role of CXCR2 in cigarette smoke-induced lung inflammation
Thatcher, T. H., McHugh, N. A., Egan, R. W., Chapman, R. W., Hey, J. A., Turner, C. K., Redonnet, M. R., Seweryniak, K. E., Sime, P. J., & Phipps, R. P. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00039.2005 · Cited by 164
Wislez, M., Fujimoto, N., Izzo, J. G., Hanna, A. E., Cody, D. D., Langley, R. R., Tang, H., Burdick, M. D., Sato, M., Minna, J. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3842 · Cited by 164
Fang, W., Ye, L., Shen, L., Cai, J., Huang, F., Wei, Q., Fei, X., Chen, X., Guan, H., Wang, W., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu060 · Cited by 163
Singh, S., Sadanandam, A., Nannuru, K. C., Varney, M. L., Mayer‐Ezell, R., Bond, R. W., & Singh, R. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2387 · Cited by 160
Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer
Hardaway, A., Herroon, M. K., Rajagurubandara, E. N., & Podgorski, I. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9714-5 · Cited by 160
Zhang, T., Tseng, C., Zhang, Y., Sirin, O., Corn, P. G., Li-Ning-Tapia, E. M., Troncoso, P., Davis, J., Pettaway, C., Ward, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11674 · Cited by 160
Richardson, R. M., Marjoram, R. J., Barak, L. S., & D, R. S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2904 · Cited by 159
Podolin, P. L., Bolognese, B. J., Foley, J. J., Schmidt, D. B., Buckley, P. T., Widdowson, K. L., Jin, Q., White, J. R., Lee, J. M., Goodman, R. B., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6435 · Cited by 159
Sumida, H., Yanagida, K., Kita, Y., Abe, J., Matsushima, K., Nakamura, M., Ishii, S., Sato, S., & Shimizu, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302959 · Cited by 156
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema
Tanino, M. A. (2002) · Thorax · doi:10.1136/thorax.57.5.405 · Cited by 156
Common origins of lung cancer and COPD
Houghton, A. M., Mouded, M., & Shapiro, S. D. (2008) · Nature Medicine · doi:10.1038/nm1008-1023 · Cited by 153
Roh, Y. S., Zhang, B., Loomba, R. S., & Seki, E. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00031.2015 · Cited by 152
Coelho, F. M., Pinho, V., Amaral, F. A., Sachs, D., Costa, V. V., Rodrigues, D. H., Vieira, A. T., Silva, T. A., Souza, D. G., Bertini, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23622 · Cited by 151
Ahuja, S. K., Lee, J. C., & Murphy, P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.225 · Cited by 150
Raghuwanshi, S. K., Su, Y., Singh, V., Haynes, K., Richmond, A. J., & Richardson, R. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201114 · Cited by 150
Moghaddam, S. J., Li, H., Cho, S.-N., Dishop, M. K., Wistuba, I. I., Ji, L., Kurie, J. M., Dickey, B. F., & DeMayo, F. J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0198oc · Cited by 149
CXCR2 Is Critical to Hyperoxia-Induced Lung Injury
Sue, R. D., Belperio, J. A., Burdick, M. D., Murray, L. A., Xue, Y., Dy, M. C., Kwon, J. J., Keane, M. P., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3860 · Cited by 149
Ning, Y., LaBonte, M. J., Zhang, W., Bohanes, P. O., Gerger, A., Yang, D., Benhaïm, L., Páez, D., Rosenberg, D. O., Venkata, K. C. N., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0915 · Cited by 148
Differential Cross-regulation of the Human Chemokine Receptors CXCR1 and CXCR2
Richardson, R. M., Pridgen, B. C., Haribabu, B., Ali, H., & D, R. S. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23830 · Cited by 148
Chapman, R. W., Minnicozzi, M., Celly, C. S., Phillips, J. E., Kung, T. T., Hipkin, R. W., Fan, X., Rindgen, D., Deno, G., Bond, R. W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119040 · Cited by 148
Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer
Campbell, L. M., Maxwell, P. J., & Waugh, D. J. J. (2013) · Pharmaceuticals · doi:10.3390/ph6080929 · Cited by 147
First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers
Vág, T., Gerngroß, C., Herhaus, P., Eiber, M. J., Philipp‐Abbrederis, K., Graner, F.-P., Ettl, J., Keller, U. B., Wester, H., & Schwaiger, M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161034 · Cited by 147
The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma
Mestas, J., Burdick, M. D., Reckamp, K. L., Pantuck, A. J., Figlin, R. A., & Strieter, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5351 · Cited by 146
Patsialou, A., Wang, Y., Lin, J., Whitney, K. D., Goswami, S., Kenny, P. A., & Condeelis, J. S. (2012) · Breast Cancer Research · doi:10.1186/bcr3344 · Cited by 146
Lazaar, A. L., Sweeney, L. E., MacDonald, A. J., Alexis, N. E., Chen, C., & Tal‐Singer, R. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03968.x · Cited by 145
Griego, S. D., Weston, C. B., Adams, J. L., Tal‐Singer, R., & Dillon, S. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5211 · Cited by 144
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis
Wente, M. N., Keane, M. P., Burdick, M. D., Frieß, H., Büchler, M. W., Ceyhan, G. O., Reber, H. A., Strieter, R. M., & Hines, O. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.10.041 · Cited by 142
Autocrine Growth Effect of IL-8 and GRO?? on a Human Pancreatic Cancer Cell Line, Capan-1
Takamori, H., Oades, Z. G., Hoch, R. C., Burger, M., & Schraufstätter, I. U. (2000) · Pancreas · doi:10.1097/00006676-200007000-00051 · Cited by 142
The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
Bento, A. F., Leite, D. F. P., Claudino, R. F., Hara, D. B., Leal, P. C., & Calixto, J. Β. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408231 · Cited by 142
Cugini, D., Azzollini, N., Gagliardini, E., Cassis, P., Bertini, R., Colotta, F., Noris, M., Remuzzi, G., & Benigni, A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00272.x · Cited by 140
Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration
Govindaraju, V., Michoud, M.-C., Al-Chalabi, M., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2005 · Cited by 140
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
Reis, S. T., Leite, K. R. M., Piovesan, L. F., Pontes‐Júnior, J., Viana, N. I., Abe, D. K., Crippa, A., Moura, C. M., Adonias, S. P., Srougi, M., et al. (2012) · BMC Urology · doi:10.1186/1471-2490-12-18 · Cited by 140
Woolhouse, I. (2002) · Thorax · doi:10.1136/thorax.57.8.709 · Cited by 140
CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Matsuo, Y., Raimondo, M., Woodward, T. A., Wallace, M. B., Gill, K. R., Tong, Z., Burdick, M. D., Yang, Z., Strieter, R. M., Hoffman, R. M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24383 · Cited by 140
Role of the Chemokine Receptor CXCR2 in Bleomycin-Induced Pulmonary Inflammation and Fibrosis
Russo, R. C., Guabiraba, R., Garcia, C. C., Barcelos, L. S., Roffê, E., Souza, A. L. S., Amaral, F. A., Cisalpino, D., Cassali, G. D., Doni, A., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0364oc · Cited by 139
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
Varney, M. L., Singh, S., Li, A., Mayer‐Ezell, R., Bond, R. W., & Singh, R. K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.004 · Cited by 139
Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice
Zarbock, A., Allegretti, M., & Ley, K. F. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.270 · Cited by 137
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
Gabellini, C., Trisciuoglio, D., Desideri, M., Candiloro, A., Ragazzoni, Y., Orlandi, A., Zupi, G., & Bufalo, D. D. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.007 · Cited by 137
Gao, Y., Guan, Z., Chen, J., Xie, H., YANG, Z., Fan, J., Wang, X., & Li, L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3041 · Cited by 136
Kawamura, M., Toiyama, Y., Tanaka, K., Saigusa, S., Okugawa, Y., Hiro, J., Uchida, K., Mohri, Y., Inoue, Y., & Kusunoki, M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.032 · Cited by 136
Feoktistov, I., Goldstein, A. E., & Biaggioni, I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23035-2 · Cited by 133
IL-8 Reduced Tumorigenicity of Human Ovarian Cancer In Vivo Due to Neutrophil Infiltration
Lee, L., Hellendall, R. P., Wang, Y., Haskill, J. S., Mukaida, N., Matsushima, K., & Ting, J. P. ‐. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2769 · Cited by 132
Shang, K., Bai, Y., Wang, C., Wang, Z., Gu, H.-Y., Du, X., Zhou, X.-Y., Zheng, C.-L., Chi, Y.-Y., Mukaida, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051848 · Cited by 132
β-Arrestins Regulate Interleukin-8-induced CXCR1 Internalization
Barlic, J., Khandaker, M. H., Mahon, E. S., Andrews, J. D., DeVries, M. E., Mitchell, G. B., Rahimpour, R., Tan, C. M., Ferguson, S. S. G., & Kelvin, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16287 · Cited by 131
CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
Wald, O., Shapira, O. M., & Izhar, U. (2013) · Theranostics · doi:10.7150/thno.4922 · Cited by 131
Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist
Gonsiorek, W., Fan, X., Hesk, D., Fossetta, J. D., Qiu, H., Jakway, J. P., Billah, M. M., Dwyer, M. P., Chao, J., Deno, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118927 · Cited by 130
2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors
Allegretti, M., Bertini, R., Cesta, M. C., Bizzarri, C., Bitondo, R. D., Cioccio, V. D., Galliera, E., Berdini, V., Topai, A., Zampella, G., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049082i · Cited by 129
Rose, J. J., Foley, J. F., Murphy, P. M., & Venkatesan, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401364200 · Cited by 129
Iwasaki, M., Zhao, H., Jaffer, T., Unwith, S., Benzonana, L. L., Lian, Q., Sakamoto, A., & Ma, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8304 · Cited by 129
Nourbakhsh, M., Kälble, S., Dörrie, A., Häuser, H., Resch, K., & Kracht, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007532200 · Cited by 128
Airway epithelial cell inflammatory signalling in cystic fibrosis
Jacquot, J. P., Tabary, O., Rouzic, P. L., & Clément, A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.002 · Cited by 127
Wilson, C., Purcell, C., Seaton, A., Oladipo, O., Maxwell, P. J., O’Sullivan, J. M., Wilson, R. H., Johnston, P. G., & Waugh, D. J. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143826 · Cited by 127
Fiedler, M. A., Wernke-Dollries, K., & Stark, J. M. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.2.3149 · Cited by 127
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
Singh, S., Nannuru, K. C., Sadanandam, A., Varney, M. L., & Singh, R. K. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605055 · Cited by 126
Bolitho, C., Hahn, M. A., Baxter, R. C., & Marsh, D. J. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0107 · Cited by 126
The role of EGF ‐ EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
Huang, P., Xu, X., Wang, L., Zhu, B., Wang, X., & Xia, J. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12153 · Cited by 123
Varney, M. L., Johansson, S. L., & Singh, R. K. (2005) · American Journal of Clinical Pathology · doi:10.1309/vpl5r3jr7f1d6v03 · Cited by 123
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0053-3 · Cited by 1,260
Cambier, S., Gouwy, M., & Proost, P. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00974-6 · Cited by 591
Interleukin-8: An evolving chemokine
Matsushima, K., Yang, D., & Oppenheim, J. J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155828 · Cited by 520
Motzer, R. J., Robbins, P. B., Powles, T., Albiges, L., Haanen, J. B., Larkin, J., Mu, X. J., Ching, K. A., Uemura, M., Pal, S. K., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1044-8 · Cited by 518
Metadata
- Authors
- Ha, H., Debnath, B., & Neamati, N.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 7
- Issue
- 6
- Pages
- 1543-1588
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2611412386
- Cited by
- 789
- References
- 434
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.